Literature DB >> 3610813

Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as beta-inhibin.

J Y Dubé, G Frenette, R Paquin, P Chapdelaine, J Tremblay, R R Tremblay, C Lazure, N Seidah, M Chrétien.   

Abstract

In addition to other known markers of the human prostate, it was shown that the prostatic fraction of the split ejaculate was rich in a 16-kDa protein with properties not described previously. This protein was purified from human seminal plasma using ammonium sulfate precipitation, DEAE-Sepharose CL-6B ion exchange chromatography, and gel filtration on Sephadex G-100. The purified protein showed a single prominent spot on two-dimensional gel electrophoresis. The sequence of the first 40 amino acids that could be positively identified was identical to that of a prostatic secretory protein of 94 amino acids (PSP94) previously designated as beta-inhibin. Antibodies produced in rabbits against the purified protein were used to develop a radioimmunoassay. These antibodies appeared to recognize only the NH2-terminal portion of the native molecule since they did not react with a synthetic peptide composed of the 28 C-terminal residues. The radioimmunoassay showed that the concentration of the protein was 1320 +/- 183 micrograms/ml in the seminal plasma of adult fertile men and 1134 +/- 136 micrograms/ml in vasectomized patients. In hypertrophic and adenocarcinomatous prostates, the concentrations were 326 +/- 156 and 104 +/- 23 micrograms/ml, respectively, while values were lower than 0.060 micrograms/ml in the testis, epididymis, vas deferens and liver. The blood plasma concentration was 0.019 +/- microgram/ml in 23 asymptomatic men 45 to 65 years old and 0.115 +/- 0.036 microgram/ml in eight patients with prostate cancer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610813     DOI: 10.1002/j.1939-4640.1987.tb02429.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  8 in total

Review 1.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

2.  Beta microseminoprotein is not a prostate-specific protein. Its identification in mucous glands and secretions.

Authors:  H Weiber; C Andersson; A Murne; G Rannevik; C Lindström; H Lilja; P Fernlund
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

3.  Characterization of ostrich (Struthio camelus) beta-microseminoprotein (MSP): identification of homologous sequences in EST databases and analysis of their evolution during speciation.

Authors:  C Lazure; M Villemure; D Gauthier; R J Naudé; M Mbikay
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

Review 4.  MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.

Authors:  Siobhan Sutcliffe; Angelo M De Marzo; Karen S Sfanos; Martin Laurence
Journal:  Prostate       Date:  2014-01-24       Impact factor: 4.104

5.  The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.

Authors:  H von der Kammer; C Jurincic-Winkler; R Horlbeck; K F Klippel; H U Pixberg; K H Scheit
Journal:  Urol Res       Date:  1993-05

6.  Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

Authors:  S Gagnon; B Têtu; J Y Dubé; R R Tremblay
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Purification and preliminary X-ray crystallographic studies of beta-microseminoprotein from human seminal plasma.

Authors:  Vijay Kumar; Yvette Roske; Nagendra Singh; Udo Heinemann; Tej P Singh; Savita Yadav
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-04-24

8.  Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.

Authors:  Ju Yeon Ban; Koo Han Yoo
Journal:  Int Neurourol J       Date:  2014-06-26       Impact factor: 2.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.